COVID 19 rapid evidence summary: Remdesivir for treating hospitalised patients with suspected or confirmed COVID-19 (ES27)

Review suggests the following factors require consideration when using remdesivir; timing of initiation of treatment at onset of symptoms, disease severity (oxygen support, non-invasive/ invasive ventilation or organ support) and underlying clinical status of patient and age.


National Institute for Health and Care Excellence